| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Adma Biologics, Inc. (ADMA) has 9 insiders with recent SEC Form 4 filings, including 8 buys and 2 sells. ADMA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.26M | $18.35M | - | |
| Dir | 2.05M | $16.61M | - | |
| Dir | 488.9K | $3.97M | - | |
| COO | 446.2K | $3.62M | - | |
| Dir | 263.0K | $2.14M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 8, 2018 | Guiheen Lawrence P.70 | Director | Buy | 20,000 | $4.78 | $95,600.00 | +400.0% | |
| May 14, 2018 | Biotest AG | 10% Owner | Sell | 8,591,160 | $0.00 | - | -100% | |
| May 14, 2018 | Biotest Divestiture Trust | 10% Owner | Sell | 8,591,160 | $0.00 | - | -100% | |
| Nov 9, 2017 | Richman Eric I79 | Director | Buy | 25,000 | $2.15 | $53,750.00 | +396.8% | |
| Nov 9, 2017 | Biotest AG | Director, 10% Owner | Buy | 5,813,954 | $2.15 | $12,500,001.10 | +135.3% | |
| Nov 9, 2017 | Lenz Brian | VP, CFO | Buy | 6,500 | $2.15 | $13,975.00 | +76.5% | |
| Nov 9, 2017 | Grossman Adam S66 | President And CEO | Buy | 485,000 | $2.15 | $1,042,750.00 | +187.3% | |
| Nov 9, 2017 | Mond James | EVP, CSO And CMO | Buy | 10,000 | $2.15 | $21,500.00 | +295.1% | |
| May 3, 2016 | Grossman Jerrold B68 | Director | Buy | 45,769 | $6.50 | $297,498.50 | +75.6% | |
| May 3, 2016 | Mond James | Cso/ CMO | Buy | 770 | $6.50 | $5,005.00 | +29.4% |